KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Top Cited Papers
- 1 October 2009
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 36 (1), 131-140
- https://doi.org/10.1016/j.molcel.2009.07.025
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder CancerGastroenterology, 2008
- All Roads Lead to mTOR: Integrating Inflammation and Tumor AngiogenesisCell Cycle, 2007
- The Genomic Landscapes of Human Breast and Colorectal CancersScience, 2007
- A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activityBiochemical and Biophysical Research Communications, 2007
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLoS Medicine, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerThe Lancet, 2005
- Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase ComplexMolecular and Cellular Biology, 2004
- IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3aCell, 2004